79 related articles for article (PubMed ID: 21941959)
21. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T
Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506
[TBL] [Abstract][Full Text] [Related]
22. Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours.
Crook T; Wrede D; Tidy JA; Mason WP; Evans DJ; Vousden KH
Lancet; 1992 May; 339(8801):1070-3. PubMed ID: 1349102
[TBL] [Abstract][Full Text] [Related]
23. [Relationship between nitric oxide in cervical microenvironment and different HPV types and effect on cervical cancer cells].
Wei XM; Wang Q; Gao SJ; Sui L
Zhonghua Fu Chan Ke Za Zhi; 2011 Apr; 46(4):260-5. PubMed ID: 21609578
[TBL] [Abstract][Full Text] [Related]
24. Expression pattern of AP-2 transcription factors in cervical cancer cells and analysis of their influence on human papillomavirus oncogene transcription.
Beger M; Butz K; Denk C; Williams T; Hurst HC; Hoppe-Seyler F
J Mol Med (Berl); 2001 Jun; 79(5-6):314-20. PubMed ID: 11485026
[TBL] [Abstract][Full Text] [Related]
25. Differential response of normal and HPV immortalized ectocervical epithelial cells to B[a]P.
Sizemore N; Mukhtar H; Couch LH; Howard PC; Rorke EA
Carcinogenesis; 1995 Oct; 16(10):2413-8. PubMed ID: 7586144
[TBL] [Abstract][Full Text] [Related]
26. Presence of irregularity in region between -1115 and -784 nt in P1 promoter of insulin-like growth factor-1 gene may indicate beneficial effect on coronary arteries in a group of patients with stable angina: preliminary data.
Burchardt P; Nowak W; Gozdzicka-Jozefiak A; Link R; Grotowski T; Wisniecka A; Siminiak T
Heart Vessels; 2009 Jul; 24(4):254-9. PubMed ID: 19626396
[TBL] [Abstract][Full Text] [Related]
27. Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer.
Combes JD; Pawlita M; Waterboer T; Hammouda D; Rajkumar T; Vanhems P; Snijders P; Herrero R; Franceschi S; Clifford G
Int J Cancer; 2014 Nov; 135(10):2453-61. PubMed ID: 24729277
[TBL] [Abstract][Full Text] [Related]
28. HPV 16 detection in cervical lesions, physical state of viral DNA and changes in p53 gene.
do Horto dos Santos Oliveira L; Rodrigues Ede V; de Salles Lopes AP; Fernandez Ade P; Cavalcanti SM
Sao Paulo Med J; 2003 Mar; 121(2):67-71. PubMed ID: 12870053
[TBL] [Abstract][Full Text] [Related]
29. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
[TBL] [Abstract][Full Text] [Related]
30. IL-10 gene polymorphism c.-592C>A increases HPV infection susceptibility and influences IL-10 levels in HPV infected women.
Berti FCB; Pereira APL; Trugilo KP; Cebinelli GCM; Silva LFDRS; Lozovoy MAB; Simão ANC; Watanabe MAE; de Oliveira KB
Infect Genet Evol; 2017 Sep; 53():128-134. PubMed ID: 28552689
[TBL] [Abstract][Full Text] [Related]
31. Nuclear proto-oncogene products transactivate the human papillomavirus type 16 promoter.
Nürnberg W; Artuc M; Vorbrueggen G; Kalkbrenner F; Moelling K; Czarnetzki BM; Schadendorf D
Br J Cancer; 1995 May; 71(5):1018-24. PubMed ID: 7734293
[TBL] [Abstract][Full Text] [Related]
32. Polymorphic CA repeats in the IGF-I gene and breast cancer.
Yu H; Li BD; Smith M; Shi R; Berkel HJ; Kato I
Breast Cancer Res Treat; 2001 Nov; 70(2):117-22. PubMed ID: 11768601
[TBL] [Abstract][Full Text] [Related]
33. Correlation of plasma nitrite/nitrate levels and inducible nitric oxide gene expression among women with cervical abnormalities and cancer.
Sowjanya AP; Rao M; Vedantham H; Kalpana B; Poli UR; Marks MA; Sujatha M
Nitric Oxide; 2016 Jan; 52():21-8. PubMed ID: 26435258
[TBL] [Abstract][Full Text] [Related]
34. Expression of p53 protein related to the presence of human papillomavirus (HPV) DNA in genital carcinomas and precancer lesions.
Tervahauta AI; Syrjänen SM; Väyrynen M; Saastamoinen J; Syrjänen KJ
Anticancer Res; 1993; 13(4):1107-11. PubMed ID: 8394670
[TBL] [Abstract][Full Text] [Related]
35. Survivin promoter polymorphism and cervical carcinogenesis.
Borbély AA; Murvai M; Szarka K; Kónya J; Gergely L; Hernádi Z; Veress G
J Clin Pathol; 2007 Mar; 60(3):303-6. PubMed ID: 16714396
[TBL] [Abstract][Full Text] [Related]
36. IGF-I in epithelial ovarian cancer and its role in disease progression.
Brokaw J; Katsaros D; Wiley A; Lu L; Su D; Sochirca O; de la Longrais IA; Mayne S; Risch H; Yu H
Growth Factors; 2007 Oct; 25(5):346-54. PubMed ID: 18236213
[TBL] [Abstract][Full Text] [Related]
37. Molecular biology of cervical cancer and its precursors.
Park TW; Fujiwara H; Wright TC
Cancer; 1995 Nov; 76(10 Suppl):1902-13. PubMed ID: 8634981
[TBL] [Abstract][Full Text] [Related]
38. Association of IL-10 GTC haplotype with serum level and HPV infection in the development of cervical carcinoma.
Singhal P; Kumar A; Bharadwaj S; Hussain S; Bharadwaj M
Tumour Biol; 2015 Apr; 36(4):2287-98. PubMed ID: 25412954
[TBL] [Abstract][Full Text] [Related]
39. [Human papillomatosis viruses and cervical cancer].
Vasil'ev MIu
Eksp Onkol; 1989; 11(2):8-12. PubMed ID: 2544395
[TBL] [Abstract][Full Text] [Related]
40. Association of the (CA)n repeat polymorphism of insulin-like growth factor-I and -202 A/C IGF-binding protein-3 promoter polymorphism with adult height in patients with severe growth hormone deficiency.
Miletta MC; Scheidegger UA; Giordano M; Bozzola M; Pagani S; Bona G; Dattani M; Hindmarsh PC; Petkovic V; Oser-Meier M; Flück CE; Mullis PE
Clin Endocrinol (Oxf); 2012 May; 76(5):683-90. PubMed ID: 22026507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
